BCL-2 and MCL1 co-inhibition enhances glucocorticoid therapy in preclinical models of infant KMT2A-rearranged acute lymphoblastic leukaemia. - Karsa M; Karsa A; Spurling D; Xiao L; Ronca E; Bongers A; Gao W; Gifford AJ; El-Ayoubi A; Cheung LC; Kotecha RS; Lock RB; et al. (British journal of haematology, 2026)